Jefferies Comments on Amylin Pharm. (AMLN) Following Solid News at ADA
Tweet
Share
E-mailGet Alerts AMLN Hot Sheet
Price: $30.98 --0%
Rating Summary:
3 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Jefferies is maintaining its Buy rating and $22 price target on shares of Amylin Pharmaceuticals (NASDAQ: AMLN) following a positive weekend update at ADA.
The firm believes that the company's presentations on QT data from DURATION-1 and new data on Byetta once monthly was positive and should affect the stock in the same manner.
Jefferies also noted that the news of Lilly's (NYSE: LLY) 3mg dose of dulaglutide having been discontinued from all studies due to a recommendation of a Data Safety Monitoring Board following an undisclosed safety issue observed in long term dosing is a huge positive for the company.
The firms current 2011, 2012, and 2013 EPS estimates are ($0.57), ($0.71), and ($0.03).
For more ratings news on Amylin Pharmaceuticals click here and for the rating history of Amylin Pharmaceuticals click here.
Shares of Amylin Pharmaceuticals closed at $11.83 yesterday.
The firm believes that the company's presentations on QT data from DURATION-1 and new data on Byetta once monthly was positive and should affect the stock in the same manner.
Jefferies also noted that the news of Lilly's (NYSE: LLY) 3mg dose of dulaglutide having been discontinued from all studies due to a recommendation of a Data Safety Monitoring Board following an undisclosed safety issue observed in long term dosing is a huge positive for the company.
The firms current 2011, 2012, and 2013 EPS estimates are ($0.57), ($0.71), and ($0.03).
For more ratings news on Amylin Pharmaceuticals click here and for the rating history of Amylin Pharmaceuticals click here.
Shares of Amylin Pharmaceuticals closed at $11.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Idex Corp. (IEX) Reiterated at Buy by Stifel
- Abbott Labs (ABT) PT Raised to $135 at TD Cowen
- Walmart (WMT) PT Lowered to $120 at Baird
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
